Clinical Trial Update: Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dutogliptin in Type 2 diabetes patients receiving background glimepiride, with or without metformin or pioglitazone, has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dutogliptin (dutogliptin)

Snippet

Sponsor: Forest Laboratories | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED